US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,564.64

-13.4141-0.85%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,590.89

Open:1,579.34

Low:1,558.46

Close:1,578.03

Volume:30.16M

Turnover:2.11B

Market Cap:1.63T

Float Cap:1.57T

Loading ...

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS

Leerink Partners Remains a Hold on Amgen (AMGN)

RBC Capital Remains a Hold on Pfizer (PFE)

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

BridgeBio Real-World Study Shows Attruby Cuts ATTR-CM Clinical Worsening Risk 34% vs Pfizer’s Tafamidis

Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)

What Happens to Your Dividends When Interest Rates Stay Higher for Longer?

The Smart Investor

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4599/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1564.6166,"timestamp":1790961222888,"preClose":1578.0306,"halted":0,"volume":30156842,"delay":0,"changeRate":-0.008501,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-13.414063,"latestTime":"10-02 13:13:43 EDT","open":1579.339,"high":1590.8905,"low":1558.4647,"amount":2112871310.880038,"amplitude":0.020548,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.58996,"peRate":28.239741,"turnoverRate":0.002835,"increases":0,"decrements":7,"flats":0,"marketCap":1625838105088,"floatMarketCap":1568457430816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1590.8905,"amplitude":0.020548,"preClose":1578.0306,"low":1558.4647,"pbRate":"9.58996","latestPrice":1564.6382,"volume":30158596,"delay":0,"open":1579.339,"prevYearClose":1494.5856,"prevWeekClose":1622.7886,"prevMonthClose":1599.3274,"prevQuarterClose":1599.3274,"fiveDayClose":1622.7886,"twentyDayClose":1648.1235,"sixtyDayClose":1637.6415,"secType":"PLATE","market":"US","turnoverRate":0.002835,"peRate":28.239741,"marketCap":1625860564768,"floatMarketCap":1568479801920,"timestamp":1790961228434,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191747742","title":"Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1191747742","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191747742?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:51","pubTimestamp":1790239896,"startTime":"0","endTime":"0","summary":"The key takeaway is that Novo Nordisk laid out ambitious goals on Monday, planning to launch at least five potential blockbuster drugs by 2030, yet its share price plunged 8% after the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","LU1093756325.SGD","LU0154236417.USD","NVOX","OZEM","PPH","THNR","BK4599","BK4007","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","NVOC","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463318","title":"Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:31","pubTimestamp":1790238660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.8% to 5.59 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 52.8 million shares, compared to the 50-day average of 85.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4585","BK1515","LU0289739699.SGD","BK4599","IE0002141913.USD","LU0109394709.USD","PJP","IE00B2B36J28.USD","LU0889565916.HKD","BK1589","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4534","LU0122379950.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BBH","BK4588","LU2112291526.USD","BK4566","LU1061106388.HKD","IE00BZ08YR35.GBP","LU2242646821.SGD","BK1191","IE00BZ08YT58.USD","BK4581","BIB","IE0009355771.USD","HK0000165453.HKD","LU1057294990.SGD","LU0868494617.USD","PBE","TBXU","IBBQ","01177","SG9999001440.SGD","LU0058720904.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","IE00BZ08YS42.EUR","AMGN","BK1521","BK4533","IBB","LU2089984988.USD","LU2242652126.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669468530","title":"Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2669468530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669468530?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:03","pubTimestamp":1790237015,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","OZEM","THNR","VKTX","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669381451","title":"Leerink Partners Remains a Hold on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669381451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669381451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:15","pubTimestamp":1790226924,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Amgen. The company’s shares closed yesterday at $406.09. In addit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","PBE","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4534","LU2112291526.USD","BK4588","BBH","IE0009355771.USD","LU2242652126.USD","TBXU","BK4581","BIB","BK4566","LU0109394709.USD","LU2242646821.SGD","BK4585","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4139","IBB","LU0889565916.HKD","LU1983299246.USD","LU1057294990.SGD","PJP","LU0868494617.USD","IE00BFTCPJ56.SGD","IBBQ","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","BK4533","SG9999001440.SGD","LU0058720904.USD","LU1023059063.AUD","LU1571399168.USD","BK4599","AMGN","IE00B2B36J28.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669255458","title":"RBC Capital Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669255458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669255458?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:46","pubTimestamp":1790214381,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh maintained a Hold rating on Pfizer on September 21 and set a price target of $25.00. The company’s shares closed ye...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-pfizer-pfe-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-pfizer-pfe-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","LU0234572021.USD","LU1883839398.USD","BK4592","IE0002270589.USD","BK4007","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1894683264.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","BK4599","LU0225284248.USD","IE00B19Z3B42.SGD","PFE","SG9999002232.USD","BK4534","LU0225771236.USD","BK4581","IE00B19Z3581.USD","LU0868494617.USD","IE00B3T34201.USD","LU1057294990.SGD","LU0122379950.USD","LU0306807586.USD","LU0170899867.USD","LU1066051498.USD","SG9999011175.SGD","BK4550","LU0321505439.SGD","BK4533","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","LU2596442595.SGD","BK4588","SG9999001176.USD","LU0306806265.USD","SG9999003800.SGD","LU1894683348.USD","SGXZ57979304.SGD","LU0321505868.SGD","BK4568","LU1023059063.AUD","SG9999013999.USD","SG9999002224.SGD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669458471","title":"RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669458471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669458471?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:45","pubTimestamp":1790214356,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh maintained a Buy rating on Eli Lilly & Co on September 21 and set a price target of $1,500.00. The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-eli-lilly-co-lly-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-eli-lilly-co-lly-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU1057294990.SGD","LU0133085943.USD","LU1291159041.SGD","SGXZ51526630.SGD","LU1551013425.SGD","LU0943347566.SGD","ELIS","LU1983299246.USD","LU2471134879.HKD","LU2168564065.EUR","LU0114720955.EUR","LU0203201768.USD","LU2237443549.SGD","LU0203202063.USD","LU1868836757.USD","LU0256863902.USD","LU2237443978.SGD","SG9999014898.SGD","LU2361044865.SGD","SG9999015952.SGD","LU0320765059.SGD","LU2023250330.USD","LU0238689110.USD","LU2324357040.USD","LU1989771016.USD","LU2237443465.HKD","LU0823434740.USD","OZEM","LU1280957306.USD","SGXZ99366536.SGD","LU0820561818.USD","LU0820561909.HKD","THNR","LU1061106388.HKD","LU2456880835.USD","LU2264538146.SGD","BK4534","LU0266013472.USD","TMED","LU0320765992.SGD","LU2552382132.HKD","LU0354030511.USD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU0471298694.HKD","LU0234572021.USD","LU0353189763.USD","SG9999015945.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2417539215.USD","SG9999015978.USD","LU0174119429.USD","IE00BWXC8680.SGD","LU1868836591.USD","LU2462591350.SGD","SG9999015986.USD","LU1623119135.USD","LU0823416689.USD","SGXZ81514606.USD","LU2552382058.USD","LU2552382215.SGD","LU2023250504.SGD","LU2357305700.SGD","LU0061475181.USD","LU2746668974.SGD","LU2168564222.USD","LU2213496289.HKD","LU0094547139.USD","LU1093756168.USD","LU2106854487.HKD","LU2168564149.EUR","IE00BFSS8Q28.SGD","LLY","MHIP","ELIL","LU2271345857.HKD","LU0683600562.USD","BK4516","LU0006306889.USD","FTXH","IE00BFTCPJ56.SGD","LU2237443622.USD","LU0158827781.USD","LU2112291526.USD","LU0708995401.HKD","IE00BJT1NW94.SGD","LU0786609619.USD","LU0471298777.SGD","LU0823434583.USD","MEDI","LU2089984988.USD","LU1069344957.HKD","JDOC","LU2111349929.HKD","LU2361045086.USD","IE00BKDWB100.SGD","LU1064131342.USD","LU1974910355.USD","LU1988902786.USD","LU2028103732.USD","LU2746668461.USD","IE00BK4W5M84.HKD","LU2023251221.USD","LU1127390331.HKD","LU0289739699.SGD","LU0109394709.USD","IYH","LU0456855351.SGD","LU1093756325.SGD","SGXZ31699556.SGD","LU0345770993.USD","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0432979614.USD","CANC","HRTS","ILDR","IE00BK4W5L77.USD","LU2237443895.HKD","LU0225283273.USD","LU1979441026.SGD","IE00B1XK9C88.USD","XLV","LU2462157665.USD","SG9999014906.USD","RXL","LU0256863811.USD","LU0353189680.USD","LU2471134523.USD","LU0672654240.SGD","PJP","LU1917777945.USD","LU2087625088.SGD","LU1145028129.USD","LU2237443382.USD","LU0210536198.USD","LU0385154629.USD","SG9999013999.USD","LU0198837287.USD","LU0689472784.USD","LU0417517546.SGD","LU2491049909.HKD","LU2168564495.EUR","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","SG9999001176.SGD","LU0466842654.USD","AGNG","LU2063271972.USD","LU1548497426.USD","LU2750360997.AUD","IE00BN29S564.USD","LU0058720904.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LLII","LU0316494557.USD","LU1551013342.USD","LU1868837300.USD","LU2468319806.SGD","GB00BDT5M118.USD","LU2108987350.USD","LU2471134796.USD","TRUH","LU2089283258.USD","IE0009355771.USD","IXJ","LU2237438978.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1804176565.USD","LU0323591593.USD","LU1323610961.USD","SG9999014880.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU2089284900.SGD","LU0889565916.HKD","BK4588","LU1267930730.SGD","LU1035775433.USD","LU1712237335.SGD","LU0079474960.USD","IE0001KFT4U8.USD","IE0004445015.USD","LU1720051108.HKD","MEDX","LU0882574055.USD","LU2750360641.GBP","IE00B7KXQ091.USD","LU0097036916.USD","LU2756315318.SGD","CURE","SG9999001176.USD","GDOC","LLYX","LU0640476718.USD","LU0345770308.USD","LU1629891620.HKD","LU1720051017.SGD","SG9999014914.USD","LU2236285917.USD","SG9999018857.SGD","FHLC","LU2360106947.USD","BK4007","BK4533","IE00BFSS7M15.SGD","LU0122379950.USD","LU0882574139.USD","LU2491050071.SGD","LU1023059063.AUD","LU2896262040.SGD","LU2361044949.HKD","WDNA","LU1814569148.SGD","IE00BJJMRX11.SGD","LU1868836914.USD","LU0354030438.USD","LLYZ","VHT","IE00B775H168.HKD","LU2471134952.CNY","IHE","LU2491050154.USD","LU0096364046.USD","LU1232071149.USD","PPH","LU2602419157.SGD","IE0004445239.USD","LU0158827948.USD","IE00BKPKM429.USD","LU1366192091.USD","BK4585","BK4599","LU2756315664.SGD","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU2265009873.SGD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123855393","title":"BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1123855393","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123855393?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:39","pubTimestamp":1790210367,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma announced on Wednesday that its heart disease therapy acoramidis, marketed as Attruby in the U.S., demonstrated superior performance compared to Pfizer's competing drug tafamidis,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU0225284248.USD","LU2596442595.SGD","SG9999001176.USD","LU0225771236.USD","SG9999002224.SGD","BK4592","LU0122379950.USD","BK4139","SG9999013999.USD","IE00B19Z3581.USD","SG9999011175.SGD","BK4534","LU0306807586.USD","BK4588","LU1894683348.USD","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1894683264.USD","SG9999002232.USD","LU1066053197.SGD","IE0002270589.USD","LU1057294990.SGD","BK4505","BK4550","BK4581","LU0321505868.SGD","BK4585","LU0985481810.HKD","LU1883839398.USD","LU0456855351.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0321505439.SGD","BK4533","BK4599","IE00B3T34201.USD","LU0234572021.USD","PFE","BK4568","LU0306806265.USD","SG9999001176.SGD","LU1066051498.USD","OZEM","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0868494617.USD","BK4007","BBIO","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431849","title":"Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431849?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:15","pubTimestamp":1790198123,"startTime":"0","endTime":"0","summary":"Morgan Stanley and JPMorgan are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-200m-spot-secondary-price-range-35-00-38-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-200m-spot-secondary-price-range-35-00-38-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXO","BK4533","TRUF","KBWB","LU0211327993.USD","PGF","XLF","BK4599","LU0106831901.USD","LU1116320901.HKD","LU2168564149.EUR","IE00BDCRKT87.USD","LU1720051017.SGD","IYG","JPO","IAI","VFH","LU2357627491.SGD","LU0417517546.SGD","LU0820561909.HKD","LU0964807845.USD","LU0211328371.USD","LU0795875086.SGD","THNR","LU2111349929.HKD","LU0234572021.USD","BK4139","LU1280957306.USD","LU2237443895.HKD","LU1791710582.SGD","LU2237443549.SGD","IYF","BK4504","FNCL","LU2430703178.SGD","IXG","IE000MB6IJN5.SGD","IE00BK4W5M84.HKD","LU0496365809.HKD","TFNS","LU1267930490.SGD","BK4588","LU1074936037.SGD","VKTX","LU0557290698.USD","LU0912757837.SGD","OZEM","JPMO","UYG","LU1244550494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143641","title":"Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143641","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143641?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195616,"startTime":"0","endTime":"0","summary":"Viking Therapeutics plans USD 200 million convertible senior notes offering due 2032Viking Therapeutics launched a public offering of USD 200 million convertible senior notes due 2032.Underwriters hol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL8YlXBZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4599","VKTX","BK4585","OZEM","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436418","title":"Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436418?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","VKTX","OZEM","BK4599","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436413","title":"Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436413?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4588","THNR","VKTX","OZEM","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669364904","title":"Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669364904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669364904?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","THNR","BK4585","OZEM","BK4139","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436230","title":"Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436230?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:31","pubTimestamp":1790195460,"startTime":"0","endTime":"0","summary":"DJ Eli Lilly & Co. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  slipped 1.64% to $1,150.99 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.75% to 7,706.03 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.The stock's fall snapped a five-day winning streak.Eli Lilly & Co. closed 10.96% short of its 52-week high of $1,292.65, which the company achieved on August 19th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.01% to $269.17, Pfizer Inc.  rose 0.90% to $28.18, and AbbVie Inc.  fell 0.05% to $265.08.Trading volume  remained 443,603 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0943347566.SGD","LU1057294990.SGD","LU2089284900.SGD","SG9999018865.SGD","LU1988902786.USD","LU2168564065.EUR","LU0320765992.SGD","LU1064131342.USD","IE00BN29S564.USD","LU0210536198.USD","LU2111349929.HKD","LU2211815571.USD","LU2324357040.USD","LU1868836591.USD","HRTS","MEDI","IE00BK4W5M84.HKD","LU2456880835.USD","BK4599","LU0106261372.USD","LU1551013342.USD","IE00BJJMRX11.SGD","LU0889565916.HKD","LU0689472784.USD","CANC","LU1989771016.USD","GB00BDT5M118.USD","TMED","IE00BFSS7M15.SGD","LU2237443382.USD","LU2264538146.SGD","IE0004445239.USD","LLYZ","MEDX","IE0002141913.USD","LU0345770308.USD","LU0820562030.AUD","LU0238689110.USD","IE00B2B36J28.USD","LU2112291526.USD","WDNA","LU0354030438.USD","LU2746668974.SGD","LU1023059063.AUD","LU2471134879.HKD","LU0354030511.USD","LU1720051017.SGD","SG9999018857.SGD","LU0109391861.USD","LU2552382215.SGD","LU0203201768.USD","LU2750360641.GBP","FTXH","LU0708995401.HKD","BK4533","LU2360106947.USD","MHIP","LU0323591593.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2213496289.HKD","IE00BJLML261.HKD","LU0198837287.USD","LU0353189763.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","SG9999015986.USD","LU2237443549.SGD","LU1814569148.SGD","LU2106854487.HKD","LU1232071149.USD","LU2237443465.HKD","SGXZ51526630.SGD","LU2063271972.USD","LU2361044865.SGD","ELIS","BK4007","IE0001KFT4U8.USD","LU1280957306.USD","SG9999001176.USD","IE00B775H168.HKD","LU2471134523.USD","SG9999013999.USD","BK4585","SGXZ99366536.SGD","VHT","LU0820561909.HKD","LU1551013425.SGD","LU2602419157.SGD","LU1983299246.USD","LU0320765059.SGD","LU0820561818.USD","LU2023250330.USD","JDOC","LU1127390331.HKD","LU2168564222.USD","IE0009355771.USD","LU0203202063.USD","LU0234572021.USD","LU0640476718.USD","LU1366192091.USD","LU1868837300.USD","LU1868836757.USD","LU0353189680.USD","THNR","SG9999001176.SGD","XLV","IE00BWXC8680.SGD","LU1323610961.USD","LU1623119135.USD","LU1979441026.SGD","SG9999014880.SGD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","LU0289739699.SGD","PPH","LU0225283273.USD","LU1093756325.SGD","FHLC","LU2087625088.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2468319806.SGD","SG9999014914.USD","LU0174119429.USD","LU2417539215.USD","ILDR","LU1917777945.USD","LU2552382132.HKD","LU0385154629.USD","BK4534","LLYX","LU0079474960.USD","LU2357305700.SGD","LU1629891620.HKD","LU1691799644.USD","LU2265009873.SGD","LU2552382058.USD","LU2168564495.EUR","LU1035775433.USD","LU2756315318.SGD","LU0417517546.SGD","LLY","LU1712237335.SGD","BK4516","IE0005OL40V9.USD","LU0096364046.USD","LU0471298777.SGD","OZEM","LU0114720955.EUR","LU0006306889.USD","LU0256863811.USD","LU0094547139.USD","LU1720051108.HKD","LU0683600562.USD","LU2471134796.USD","LU0058720904.USD","LU0823416689.USD","LU0345770993.USD","LU2471134952.CNY","IE00BFSS8Q28.SGD","LU0133085943.USD","AGNG","IE0004445015.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LU0882574055.USD","LU2168564149.EUR","LU0256863902.USD","LU1061106388.HKD","GDOC","LU0316494557.USD","LU0823434583.USD","LU2089984988.USD","LU2361044949.HKD","LU2750360997.AUD","SG9999014898.SGD","IE00B1XK9C88.USD","LU1868837136.USD","LU0823434740.USD","LU0158827781.USD","LU2237438978.USD","LU2271345857.HKD","LU1093756168.USD","SG9999015952.SGD","LU2023251221.USD","LU2089283258.USD","LU1145028129.USD","LU2491050154.USD","LU2236285917.USD","ELIL","LU0432979614.USD","IE00B1BXHZ80.USD","SG9999017495.SGD","LU0787776722.HKD","SGXZ81514606.USD","LU2461242641.AUD","LU2756315664.SGD","LU1548497426.USD","LU0122379950.USD","SG9999015978.USD","LU0466842654.USD","LU1804176565.USD","LU0882574139.USD","LU2491050071.SGD","LU0786609619.USD","LU1974910355.USD","LU2896262040.SGD","SGXZ57979304.SGD","SG9999014906.USD","BK4581","IYH","CURE","LU2108987350.USD","LU1291159041.SGD","LU2168563687.JPY","RXL","LU2237443622.USD","TRUH","LU0672654240.SGD","LU2023250504.SGD","LU0158827948.USD","LU2028103732.USD","LU2237443978.SGD","LU0097036916.USD","LU2361045086.USD","LU2491049909.HKD","IE00BKPKM429.USD","LU2462157665.USD","LU1868836914.USD","IHE","LLII","IE00BJT1NW94.SGD","PJP","IXJ","LU0061475181.USD","LU1069344957.HKD","IE00BKDWB100.SGD","LU2746668461.USD","LU0109394709.USD","LU0471298694.HKD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436112","title":"Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436112","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436112?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:15","pubTimestamp":1790194525,"startTime":"0","endTime":"0","summary":"• Novo Nordisk shares dropped following disappointing long-term revenue growth targets.\n• Intensifying competition, patent cliff risks, and market share losses weighed heavily.\n• Technical indicators show sell signals with an RSI of 27.877.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262183539-market-movers-nvo-20260923","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","IE00BZ1G4Q59.USD","NVOC","OZEM","BK4007","IE00BKVL7J92.USD","THNR","BK4532","NVOX","BK4599","BK4588","NVO","LU0154236417.USD","BK4585","LU1093756325.SGD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669791487","title":"Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2669791487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669791487?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:02","pubTimestamp":1790179320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 2.5% to DKK252.25 Wednesday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,648.31.This was the stock's third consecutive day of losses.The company closed DKK157.70 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,754,249, compared to the 50-day average trading volume of 4,611,738.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4599","BK4588","LU1093756168.USD","NVOH","OZEM","IE00BZ1G4Q59.USD","THNR","BK4007","LU0154236417.USD","NVO","LU1093756325.SGD","NVOC","NVOX","PPH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669826694","title":"Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669826694","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669826694?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:40","pubTimestamp":1790174414,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) this week announced topline results from the phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly CagriSema, an investigatio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","NVOC","BK4599","LU1093756325.SGD","IE00BKVL7J92.USD","OZEM","NVOH","BK4588","LU1093756168.USD","BK4007","PPH","BK4532","THNR","BK4585","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483841","title":"BridgeBio Real-World Study Shows Attruby Cuts ATTR-CM Clinical Worsening Risk 34% vs Pfizer’s Tafamidis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483841","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483841?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:47","pubTimestamp":1790164058,"startTime":"0","endTime":"0","summary":"BridgeBio real-world study shows Attruby cuts ATTR-CM clinical worsening risk 34% vs Pfizer’s tafamidisBridgeBio reported peer-reviewed real-world study results in Cardiology and Therapy comparing its","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL3KrFk7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","LU0234572021.USD","LU1883839398.USD","BBIO","BK4592","IE0002270589.USD","BK4007","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1894683264.USD","IE00BLSP4452.SGD","BK4139","IE000M9KFDE8.USD","LU1066053197.SGD","BK4599","LU0225284248.USD","IE00B19Z3B42.SGD","PFE","SG9999002232.USD","BK4534","LU0225771236.USD","BK4581","IE00B19Z3581.USD","LU0868494617.USD","IE00B3T34201.USD","LU1057294990.SGD","LU0122379950.USD","LU0306807586.USD","LU0170899867.USD","LU1066051498.USD","SG9999011175.SGD","BK4550","LU0321505439.SGD","BK4533","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","LU2596442595.SGD","BK4588","SG9999001176.USD","LU0306806265.USD","SG9999003800.SGD","LU1894683348.USD","SGXZ57979304.SGD","LU0321505868.SGD","BK4568","LU1023059063.AUD","BK4505","SG9999013999.USD","SG9999002224.SGD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648839","title":"Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648839?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:16","pubTimestamp":1790162192,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Nash from Canaccord Genuity reiterated a Buy rating on Viking Therapeutics, with a price target of $114.00. Acco...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-viking-therapeutics-vktx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-viking-therapeutics-vktx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","OZEM","BK4585","VKTX","THNR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043011","title":"What Happens to Your Dividends When Interest Rates Stay Higher for Longer?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043011","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043011?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:30","pubTimestamp":1790155800,"startTime":"0","endTime":"0","summary":"Discover how higher-for-longer interest rates impact dividend stocks – including banks, REITs, and income investments, and what investors should monitor as borrowing costs stay elevated.","market":"nz","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2026/09/higher-for-longer-interest-rates-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2026/09/higher-for-longer-interest-rates-300x200.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/what-happens-to-your-dividends-when-interest-rates-stay-higher-for-longer/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/what-happens-to-your-dividends-when-interest-rates-stay-higher-for-longer/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["LU0823038988.USD","SG9999001069.SGD","D05.SI","SGXZ51708014.SGD","LU0955623706.USD","LU2237957902.USD","LU0165289439.USD","SG9999013460.SGD","LU0882747503.HKD","LU2238330802.EUR","LU2242646821.SGD","SGXZ53341947.SGD","BK4568","LU0868494617.USD","LU0737861269.HKD","LU0985481810.HKD","IE0031814969.USD","IE0003895053.USD","LU0819123356.HKD","LU0011963245.USD","LU0819121731.USD","LU0979878070.USD","LU0877626530.USD","LU0289739699.SGD","LU1363072403.SGD","PFE","LU0210637038.USD","LU1920062954.HKD","OZEM","SG9999009443.AUD","SG9999016042.SGD","AIY.SI","LU0320764755.SGD","LU0588545490.SGD","LU3227948356.SGD","LU0823413587.USD","SGXZ24219693.SGD","SG9999001846.SGD","LU0197773673.USD","LU2152927971.USD","SGXZ91733576.SGD","S68.SI","IE00BVYPNQ40.USD","LU0170899867.USD","SGXZ23024854.USD","SG9999001226.SGD","LU0072462343.USD","LU0577902538.SGD","IE00BGHQDM52.EUR","LU0384037296.USD","LU1048588211.SGD","IE00BLSP4452.SGD","LU1064131342.USD","LU1242518857.USD","LU1242518931.SGD","LU0251144936.SGD","LU0456855351.SGD","LU1497734951.SGD","BK6523","LU0235996351.USD","LU1497733631.SGD","SG9999008742.SGD","LU0251143029.SGD","LU0971096721.USD","LU0058720904.USD","SG9999000459.SGD","LU0205439572.USD","LU0873338254.USD","BK6503","LU0532188223.SGD","C38U.SI","LU1770036033.HKD","LU0188438112.USD","LU0441851309.USD","BK6512","LU0321505439.SGD","LU0348783662.USD","BK6112","LU0577902298.EUR","LU1504937902.USD","LU0856984785.SGD","SG9999002620.SGD","SGXZ70427877.SGD","LU1282649067.USD","IE00BVYPNP33.GBP","IE00B19Z3581.USD","LU0878005551.USD","BK6052","BK6011","SG9999013353.USD","LU0886674414.USD","SG9999001176.SGD","LU1894683348.USD","IE00B3T34201.USD","SG9999007991.SGD","BK6137","SG9999006266.SGD","SGXZ44201846.SGD","LU0588545904.SGD","LU1130305938.SGD","LU1066053197.SGD","LU0831093199.SGD","BK4585","LU0306806265.USD","SG9999014484.SGD","SG9999002562.SGD","LU0096374516.USD","LU0675040207.SGD","LU0823397103.USD","LU0955648018.USD","LU1497733557.USD","SG9999004220.SGD","BK4533","LU0823039010.USD","SG9999001176.USD","LU0557290698.USD","SG9999001127.SGD","LU0321505868.SGD","BK4534","LU1634259391.SGD","IE00BKZH1Z71.USD","IE0002270589.USD","LU2506952097.USD","LU1988902786.USD","LU1883839398.USD","LU2242646235.USD","SG9999003800.SGD","SG9999002406.SGD","LU0543330483.HKD","SG9999011175.SGD","LU0122379950.USD","LU0648948544.HKD","LU0441854154.USD","LU0588545730.USD","LU2506951958.HKD","LU0823417653.USD","SG9999001051.SGD","SG9999005177.SGD","SG9999014302.SGD","IE000M9KFDE8.USD","LU0225771236.USD","LU0192582467.USD","LU0823417737.USD","SG9999002414.USD","SG9999014492.USD","SGXZ27511609.SGD","LU0225284248.USD","LU1282649141.HKD","BK6504","LU1119993845.HKD","LU2264538146.SGD","SG9999004360.SGD","LU0831103253.SGD","LU1057294990.SGD","SG9999001135.SGD","LU2257852520.SGD","LU2293587155.HKD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU1839390173.USD","SGXZ44547263.SGD","IE00BBT3K403.USD","LU0345775950.USD","BK4592","LU0197773160.USD","SGXZ43160589.SGD","LU0348766576.USD","SGXZ16066938.SGD","BK6072","LU0950375773.USD","LU2596442595.SGD","LU0348744763.USD","LU0345776255.USD","HK0000107257.USD","LU0234572021.USD","BK4588","LU0672654166.SGD","LU0348783233.USD","S63.SI","BK6518","SG9999001903.USD","LU0577902454.USD","SG9999002679.SGD","LU0417516571.SGD","BK6516","LU0865486749.SGD","SG9999013999.USD","LU0211331839.USD","LU0306807586.USD","LU0348767384.USD","LU0898667661.SGD","LU0577902371.SGD","LU1634259557.SGD","LU0348784397.USD","LU2242652126.USD","LU0048573645.USD","LU2506952170.USD","SG9999002604.SGD","BK4007","LU1023059063.AUD","LU0577902611.USD","LU1282649810.SGD","LU0048597586.USD","LU0326948709.USD","SG9999000475.SGD","OV8.SI","LU0029875118.USD","LU0084288322.USD","LU0261945553.USD","LU0043850808.USD","SG9999013478.USD","SG9999000343.SGD","LU0823413660.USD","LU0261947096.USD","IE00BLSP4239.USD","LU0823397285.USD","SG9999002224.SGD","SG9999003925.USD","LU0061477393.USD","LU0169518387.USD","BK6094","LU0878004406.USD","LU0128522157.USD","LU0630378429.USD","LU0762540952.USD","LU0488056044.USD","LU1956131251.USD","BK4599","LU1522347837.USD","SG9999003826.SGD","SG9999002232.USD","SGXZ58947870.SGD","LU0955669360.SGD","LU1066051498.USD","LU2506951875.HKD","SG9999013486.USD","BK6034","LU2237957811.SGD","LU2401740654.USD","SG9999002950.SGD","BK6033","LU1894683264.USD","BK4550","LU0315178854.USD","BK4581","LU0630378692.HKD","LU1920063259.USD","SG9999003461.SGD","LU1211504680.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669109600","title":"Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments","url":"https://stock-news.laohu8.com/highlight/detail?id=2669109600","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669109600?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:39","pubTimestamp":1790152792,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has won approval from Singapore authorities for the use of its weight-loss drug, Wegovy, to treat certain liver diseases, the drugmaker said Wednesday.Wegovy, a once-weekly injectab","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOC","BK4007","LU0154236417.USD","OZEM","LU1093756168.USD","NVOX","THNR","BK4599","IE00BZ1G4Q59.USD","BK4585","BK4588","LU1093756325.SGD","BK4532","PPH","NVO","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":9,"totalSize":292,"code":"91000000","status":"200"}]}}